| Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders (NCT05982925) | Icahn School of Medicine at Mount Sinai | 2022-05-06 |
| Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study (NCT05245344) | Neuromed IRCCS | 2022-04-01 |
| Lifestyle Weight Management Program: Interviews and Stakeholder Meetings. (NCT05070286) | Oxford Brookes University | 2022-01-01 |
| High Frequency Impulse Therapy for Neuropathic Pain in NMOSD (NCT04614454) | Massachusetts General Hospital | 2021-06-07 |
| Association Between the Effect of Glucocorticoid Pulse Therapy on Neuromyelitis Optica (NMO) and Gene Polymorphism (NCT04601142) | Beijing Tongren Hospital | 2020-10-31 |
| Safety of Therapeutic Step-down in Neuromyelitis Optica (NCT05155644) | University Hospital, Strasbourg, France | 2020-08-01 |
| In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO (NCT04629274) | Imcyse SA | 2020-06-15 |
| A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder (NCT04155424) | Alexion Pharmaceuticals, Inc. | 2020-01-14 |
| An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD (NCT04201262) | Alexion Pharmaceuticals, Inc. | 2019-12-09 |
| Autologous Transplant To End NMO Spectrum Disorder (NCT03829566) | Northwestern University | 2019-11-01 |
| PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes. (NCT03942952) | University of Texas Southwestern Medical Center | 2019-10-22 |
| MS and NMOSD in African-Americans (NCT04131673) | Jagannadha R Avasarala | 2019-07-05 |
| Scrambler Trial for Pain in NMOSD (NCT03452176) | Johns Hopkins University | 2018-02-21 |
| Pediatric NMOSD Observational Study (NCT03766347) | Mayo Clinic | 2018-02-01 |
| Immunologic Biomarker Profile of Cerebrospinal Fluid (NCT04202055) | Centre Hospitalier Universitaire de Nīmes | 2018-01-02 |
| Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders (NCT03350633) | Tianjin Medical University General Hospital | 2017-11-01 |
| A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD (NCT03062579) | Fu-Dong Shi | 2017-02-01 |
| Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses (NCT02276963) | Johns Hopkins University | 2016-01-01 |
| Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B (NCT02283671) | Sara Varea | 2015-09-01 |
| A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis (NCT02398994) | Guy's and St Thomas' NHS Foundation Trust | 2015-03-01 |
| An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients (NCT02003144) | Alexion Pharmaceuticals, Inc. | 2015-01-12 |
| A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study) (NCT01892345) | Alexion Pharmaceuticals, Inc. | 2014-04-11 |
| Neuromyelitis Optica (NMO) & Cetirizine (NCT02865018) | Icahn School of Medicine at Mount Sinai | 2014-04-01 |
| Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses (NCT02087813) | Stanford University | 2014-03-01 |
| Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations (NCT01777412) | Johns Hopkins University | 2013-06-01 |
| C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation (NCT01759602) | Michael Levy | 2013-01-01 |
| The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders (NCT01623076) | University of Texas Southwestern Medical Center | 2012-06-01 |
| Maintenance Plasma Exchange for Neuromyelitis Optica (NCT01500681) | Mayo Clinic | 2012-06-01 |
| Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica (NCT01339455) | University of Calgary | 2011-03-01 |
| Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica (NCT01364246) | Shenzhen Beike Bio-Technology Co., Ltd. | 2010-01-01 |
| Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct (NCT01024985) | University of Sao Paulo | 2009-09-01 |
| An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica (NCT00904826) | Mayo Clinic | 2009-04-01 |
| Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders (NCT02021825) | Xuanwu Hospital, Beijing | 2009-03-01 |
| Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases (NCT00716066) | Fred Hutchinson Cancer Center | 2008-06-01 |
| Biobank For MS And Other Demyelinating Diseases (NCT00445367) | Accelerated Cure Project for Multiple Sclerosis | 2006-05-01 |
| Safety and Tolerability of Rituximab in Neuromyelitis Optica (NCT00501748) | University of California, San Francisco | 2004-01-01 |
| A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease) (NCT00304291) | State University of New York at Buffalo | 2001-08-01 |